Nicotinic acetylcholine receptor: evidence for a functionally distinct receptor on human lymphocytes.
AUTOR(ES)
Richman, D P
RESUMO
The presence of three distinct cholinergic receptors on human lymphocytes was suggested by the effects of carbamoylcholine on lymphocyte proliferation in vitro. The cells responded to both 0.1 nM and 1 microM carbamoylcholine by increased proliferation which was blocked by the muscarinic antagonist atropine. This effect occurred in both mitogen-stimulated cells (maximum effect at 24 hr) and nonstimulated cells (maximum effect at 72 hr). In contrast, 1--10 nM carbamoylcholine produced diminished in vitro proliferation, an effect which was blocked by the nicotinic antagonists alpha-bungarotoxin and d-tubocurarine.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=411633Documentos Relacionados
- Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes.
- The α-bungarotoxin binding site on the nicotinic acetylcholine receptor: Analysis using a phage–epitope library
- Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes.
- Activation and desensitization of Torpedo acetylcholine receptor: evidence for separate binding sites.
- T3 glycoprotein is functional although structurally distinct on human T-cell receptor gamma T lymphocytes.